Patient-based drug discovery's latest news
New publication: The JUMP Cell Painting dataset, studying the morphological impact of 136,000 chemical and genetic perturbations goes public
Since 2019, Ksilink has been part of the JUMP-Cell Painting Consortium, a collaboration between 10 pharmaceutical companies, six supporting technology companies, and two...
Meet us at Santa Fe Keystone Symposia on Feb. 13th & 14th, 2023!
Discover how Ksilink, myriamed and their spin-off Myrtil Biotechnologies implement deep learning to enhance high-content screening and deep-tissue phenotyping to identify...
New publication: Machine learning-aided analysis of human dopaminergic neurons
Link to publication: https://www.cell.com/stem-cell-reports/fulltext/S2213-6711(22)00423-4 In our most recent work in collaboration with colleagues from Life & Brain and the...
Meet us in Madrid!
Ksilink is presenting a poster at this year’s International Congress of Parkinson’s Disease and Movement Disorders in Madrid, Spain. If you are there, please come and discuss...
Meet us in Münster!
Ksilink is presenting 2 posters at this year’s German Stem Cell Network Conference in Münster, Germany. If you are there, please come and discuss with Karen Schmitt and Juyong...
Meet us in Nice!
Ksilink is presenting 2 posters at this year’s AFM Myology Meeting and MitoNice in Nice, France. If you are lucky enough to be there as well, you can come and discuss with Vivien...
Kick-off meeting of EnvironMENTAL
The Ksilink team is happy to participate today in the kick-off meeting of the EC-funded consortium EnvironMENTAL. The consortium, coordinated by the Charité Hospital and composed...
Myrtil Biotechnologies – our first Spin-off is born!
Based on our long-standing collaboration with myriamed GmbH and the successful establishment of an AI-powered screenable disease model for dilated cardiomyopathies, we proudly...
New publication: A step forward towards precision oncology
Ksilink is dedicated to foster patient-based therapeutic approaches including personalized strategies as a means to stratify potential targeted therapies in a clinically relevant...